HomeCompareFTHWF vs MRK

FTHWF vs MRK: Dividend Comparison 2026

FTHWF yields 4854.37% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FTHWF wins by $46695367912860.83M in total portfolio value
10 years
FTHWF
FTHWF
● Live price
4854.37%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$46695367912860.86M
Annual income
$44,876,810,646,014,304,000.00
Full FTHWF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FTHWF vs MRK

📍 FTHWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFTHWFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FTHWF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FTHWF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FTHWF
Annual income on $10K today (after 15% tax)
$412,621.36/yr
After 10yr DRIP, annual income (after tax)
$38,145,289,049,112,160,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, FTHWF beats the other by $38,145,289,049,112,160,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FTHWF + MRK for your $10,000?

FTHWF: 50%MRK: 50%
100% MRK50/50100% FTHWF
Portfolio after 10yr
$23347683956430.45M
Annual income
$22,438,405,323,007,152,000.00/yr
Blended yield
96.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FTHWF
No analyst data
Altman Z
-6.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FTHWF buys
0
MRK buys
0
No recent congressional trades found for FTHWF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFTHWFMRK
Forward yield4854.37%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$46695367912860.86M$30.7K
Annual income after 10y$44,876,810,646,014,304,000.00$950.29
Total dividends collected$46572205984798.64M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FTHWF vs MRK ($10,000, DRIP)

YearFTHWF PortfolioFTHWF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$496,137$485,436.89$11,192$351.54+$484.9KFTHWF
2$23,039,572$22,508,705.80$12,524$392.70+$23.03MFTHWF
3$1,001,528,784$976,876,442.08$14,015$438.65+$1001.51MFTHWF
4$40,758,326,108$39,686,690,308.90$15,682$489.96+$40758.31MFTHWF
5$1,553,044,993,355$1,509,433,584,419.39$17,547$547.23+$1553044.98MFTHWF
6$55,414,166,704,956$53,752,408,562,066.00$19,632$611.16+$55414166.69MFTHWF
7$1,851,759,132,797,573$1,792,465,974,423,269.50$21,963$682.53+$1851759132.78MFTHWF
8$57,961,116,348,895,450$55,979,734,076,802,050.00$24,571$762.18+$57961116348.87MFTHWF
9$1,699,586,230,697,718,300$1,637,567,836,204,399,900.00$27,486$851.08+$1699586230697.69MFTHWF
10$46,695,367,912,860,860,000$44,876,810,646,014,304,000.00$30,745$950.29+$46695367912860.83MFTHWF

FTHWF vs MRK: Complete Analysis 2026

FTHWFStock

Field Trip Health & Wellness Ltd. operates health centers that provides psychedelic therapies in North America and Europe. The company is based in Toronto, Canada.

Full FTHWF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FTHWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FTHWF vs SCHDFTHWF vs JEPIFTHWF vs OFTHWF vs KOFTHWF vs MAINFTHWF vs JNJFTHWF vs ABBVFTHWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.